• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Catalog Number IAB-05840-LWS
Device Problems No Device Output (1435); Unable to Obtain Readings (1516); Failure to Zero (1683)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/09/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the intra-aortic balloon (iab) was connected to the intra-aortic balloon pump (iabp) and the fiberoptic did not register.The iab was connected on two separate iabp with no change.As a result, a new iab was opened and successfully inserted into patient.There was a report of delay in therapy.There was no report of patient complications, serious injury or death.
 
Event Description
It was reported that the intra-aortic balloon (iab) was connected to the intra-aortic balloon pump (iabp) and the fiberoptic did not register.The iab was connected on two separate iabp with no change.As a result, a new iab was opened and successfully inserted into patient.There was a report of delay in therapy.There was no report of patient complications, serious injury or death.
 
Manufacturer Narrative
(b)(4).No iab parts was returned to teleflex chelmsford for investigation.The reported complaint of iab fos would not zero is not able to be confirmed.The product was not returned for investigation.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revived risk.This will be monitored for any developing trends.Other remarks: this report would not be likely to cause or contribute to a death or serious injury.A fiber optic sensor (fos) not connecting cannot in itself cause or contribute to a patient death or serious injury.The fos is a portion of the catheter that monitors the patient's arterial pressure.When the fiber optic pressure signal is not available, the intra-aortic balloon (iab) is still able to be used since an arterial pressure signal is available through the central lumen.Iab therapy continues to the patient uninterrupted.This system does not require the clinician to remove the iab in the event that the fos is lost.It was reported that there was no patient injury or consequence.Although, a delay while another iab is obtained this is unlikely, to cause or contribute to patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key9144836
MDR Text Key160856131
Report Number3010532612-2019-00352
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902007247
UDI-Public00801902007247
Combination Product (y/n)N
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2020
Device Catalogue NumberIAB-05840-LWS
Device Lot Number18F18C0044
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/12/2019
Initial Date FDA Received10/02/2019
Supplement Dates Manufacturer Received10/25/2019
Supplement Dates FDA Received11/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-